313 related articles for article (PubMed ID: 26429220)
1. Dangerous liaisons: doctors-in-training and the pharmaceutical industry.
Pokorny AM; Gittins CB
Intern Med J; 2015 Oct; 45(10):1085-8. PubMed ID: 26429220
[TBL] [Abstract][Full Text] [Related]
2. [Effects of a mandatory guideline that prohibit hospital doctors from accepting any form of benefits in any form from the pharmaceutical industry].
Gundermann C; Meier-Hellmann A; Bauer M; Hartmann M
Dtsch Med Wochenschr; 2010 May; 135(3):67-70. PubMed ID: 20077378
[TBL] [Abstract][Full Text] [Related]
3. Interactions between physicians and the pharmaceutical industry: what does the literature say?
Lexchin J
CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
[TBL] [Abstract][Full Text] [Related]
4. [Is it pertinent to investigate the relations between physicians and the drug industry].
Moliner J; Mozota J; Abad JM; Casaña L; Júdez D; Rabanaque MJ
Rev Calid Asist; 2009 Apr; 24(2):72-9. PubMed ID: 19426930
[TBL] [Abstract][Full Text] [Related]
5. Proposed guidelines for housestaff interaction with pharmaceutical companies.
Forrest DM; Ruedy J
Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
[TBL] [Abstract][Full Text] [Related]
6. Do ethical Guidelines make a difference to decision-making?
Osborn M; Day R; Komesaroff P; Mant A
Intern Med J; 2009 Dec; 39(12):800-5. PubMed ID: 19323704
[TBL] [Abstract][Full Text] [Related]
7. Attitudes and relationship between physicians and the pharmaceutical industry in a public general hospital in Lima, Peru.
De Ferrari A; Gentille C; Davalos L; Huayanay L; Malaga G
PLoS One; 2014; 9(6):e100114. PubMed ID: 24978481
[TBL] [Abstract][Full Text] [Related]
8. The ethics of the medical-pharmaceutical relationship.
Vashi NA; Latkowski JA
Clin Dermatol; 2012; 30(2):188-91. PubMed ID: 22330662
[TBL] [Abstract][Full Text] [Related]
9. [The attitude of physicians regarding the promotion strategies of the pharmaceutical industry].
Castresana L; Mejia R; Aznar M
Medicina (B Aires); 2005; 65(3):247-51. PubMed ID: 16042137
[TBL] [Abstract][Full Text] [Related]
10. Interactions between emergency medicine programs and the pharmaceutical industry.
Keim SM; Mays MZ; Grant D
Acad Emerg Med; 2004 Jan; 11(1):19-26. PubMed ID: 14709424
[TBL] [Abstract][Full Text] [Related]
11. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.
Fickweiler F; Fickweiler W; Urbach E
BMJ Open; 2017 Sep; 7(9):e016408. PubMed ID: 28963287
[TBL] [Abstract][Full Text] [Related]
12. Physicians' attitudes towards interaction with the pharmaceutical industry.
Alosaimi FD; Al Kaabba A; Qadi M; Albahlal A; Alabdulkarim Y; Alabduljabbar M; Alqahtani F
East Mediterr Health J; 2015 Feb; 20(12):812-9. PubMed ID: 25664520
[TBL] [Abstract][Full Text] [Related]
13. Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors.
Edwards D; Ballantyne A
Intern Med J; 2009 Mar; 39(3):191-6. PubMed ID: 19383067
[TBL] [Abstract][Full Text] [Related]
14. Doctors and drug companies.
Blumenthal D
N Engl J Med; 2004 Oct; 351(18):1885-90. PubMed ID: 15509823
[No Abstract] [Full Text] [Related]
15. The ethics of pharmaceutical industry relationships with medical students.
Rogers WA; Mansfield PR; Braunack-Mayer AJ; Jureidini JN
Med J Aust; 2004 Apr; 180(8):411-4. PubMed ID: 15089733
[TBL] [Abstract][Full Text] [Related]
16. Drug representatives: giving you lunch or stealing your soul?
Higgins SP
Dermatol Online J; 2007 Oct; 13(4):5. PubMed ID: 18319002
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical industry exposure in our hospitals: the final frontier.
Dean J; Loh E; Coleman JJ
Med J Aust; 2016 Jan; 204(1):20-2. PubMed ID: 26763810
[TBL] [Abstract][Full Text] [Related]
18. On the need for probity when physicians interact with industry.
Scott IA
Intern Med J; 2006 Apr; 36(4):265-9. PubMed ID: 16640747
[TBL] [Abstract][Full Text] [Related]
19. Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry.
Mitchell PB
Med J Aust; 2009 Sep; 191(5):273-5. PubMed ID: 19740050
[TBL] [Abstract][Full Text] [Related]
20. Australian regulator insists on greater transparency of industry payments to doctors.
Coopes A
BMJ; 2014 Oct; 349():g6335. PubMed ID: 25331811
[No Abstract] [Full Text] [Related]
[Next] [New Search]
